Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Go back to Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
(NASDAQ: CODX) Delayed: 3.37 --0 (-0%)
Previous Close $3.37    52 Week High
Open $3.37    52 Week Low
Day High $3.37    P/E N/A 
Day Low $3.37    EPS
Volume 785